Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq Analysis of Sulodexide- and Vehicle-treated TAA induced Fibrotic Mouse Liver Transcriptomes

ABSTRACT: Liver fibrosis is the formation of fibrous scar with the deposition of extracellular matrix (ECM) proteins resulting from persistent liver inflammation and has become a huge global health burden. Sulodexide is a heparinoid compound purified from porcine intestine mucosa, which consists of 80% electrophoretically fast-moving heparin and 20% dermatan sulfate, with endothelium protective function. In this study, we evaluated the therapeutic potential of sulodexide in TAA-induced liver fibrosis model. To determine the mechanism of sulodexide in the treatment of liver fibrosis, we performed high throughput sequencing of mRNA in three groups of liver tissue and identified the protective role of sulodexide on liver sinusoidal endothelial cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE216326 | GEO | 2022/10/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A time-course study of thioacetamide (TAA)-induced liver fibrosis in rats

Project description:The aim is to characterize rat liver fibrosis induced by thioacetamide (TAA). To induce hepatic fibrosis, Male Sprague Dawley rats (9-12 weeks of age and 380-420 g of weight upon arrival, supplied by Beijing Vital River laboratory animal Co., Ltd.) were treated with thioacetamide (TAA). Rat liver samples were collected from five groups of rats at week 1, 2, 4, 8 and 13 after TAA (300 mg/kg) administration three times per week while five control groups receive the same volume of 0.9% normal saline. Four biological replicates were used for each group.

2021-09-29 | E-MTAB-10547 | biostudies-arrayexpress

Next Generation Sequencing Facilitates Quantitative Analysis of Control and rhCYGB treated liver transcriptomes [TAA]

Project description:Purpose: The goal of this study is to investigate the effect of recombinant human Cytoglobin (rhCYGB) on liver fibrosis induced by TAA in mice. Method: mRNA profiles of liver tissues from TAA-control mice and TAA-rhCYGB treated mice were generated by deep sequencing. Results: The RNA-seq data confirmed that extracellular matrix-encoding genes and fibrosis-related genes were down-regulated by the rhCYGB treatment.

2020-08-25 | GSE156777 | GEO

Hepatic stellate cells isolated from PBS- or thioacetamide (TAA)-treated wild-type and Cyp1b1 knockout

Project description:Metabolomic analysis on hepatic stellate cells isolated from PBS- or thioacetamide (TAA)-treated wild-type and Cyp1b1 knockout mice was performed to determine the metabolic basis by which CYP1B1 ablation inhibits HSC activation and liver fibrosis.

2024-08-28 | MSV000095716 | MassIVE

MiR-29a regulates liver fibrosis

Project description:To confirm the mechanism of miR-29a in liver fibrosis healing, we have employed whole genome microarray expression profiling as a discovery platform to identify genes. CCl4 and TAA liver fibrosis model mouse were used for this experiment. After five weeks liver fibrosis induction period, mouse have been observed for one week (1w) or two weeks (2w) and negative control nucleotide (N.C) or miR-29a were injected every 3 days on this period. We used CCl4 1w N.C (n = 1), 1w miR-29a (n = 1), 2w N.C (n = 1), 2w miR-29a (n = 1), and also used TAA model mouse (total n = 8) liver samples for microarray analysis. We can get only one gene (PDGF-c) as a target of miR-29a which relate to liver fibrosis and down-regulated more than 1.5 times in common miR-29a injected group than N.C group. CCl4 and TAA liver fibrosis model mouse were used for this experiment. After five weeks liver fibrosis induction period, mouse have been obserbed for one week (1w) or two weeks (2w) and negative control nucleotide (N.C) or miR-29a were injected every 3 days on this period. We used CCl4 1w N.C (n = 1), 1w miR-29a (n = 1), 2w N.C (n = 1), 2w miR-29a (n = 1), and also used TAA model mouse (total n = 8) liver samples for microarray analysis.

2015-03-31 | E-GEOD-67423 | biostudies-arrayexpress

TAA Cyprus

Project description:Novel variants in TAA patinets

| PRJEB29481 | ENA

A time-course study of thioacetamide (TAA)-induced liver fibrosis in rats

Project description:A time-course study of thioacetamide (TAA)-induced liver fibrosis in rats

| PRJEB45544 | ENA

Transcriptomic profile of zebrafish liver cells in thioacetamide (TAA) model

Project description:Zebrafish transgenic lines Tg(fabp10a:dsRed), Tg(hand2:EGFP) and Tg(kdrl:ras-mCherry) in AB wild-type background were anesthetized with MS-222 and adult females were injected intraperitoneally with 500 mg/kg thioacetamide (TAA) or sterile water as a control 6 times over the course of 2 weeks. We have characterized transcriptomic profiles of FACS-isolated hepatocytes (dsRed+), stellate cells (EGFP+) and liver endothelial cells (mCherry+) from fishes treated with TAA or sterile water. Cells negative for the fluorescence were used as a control.

2021-12-23 | GSE145564 | GEO

Acidobacteriaceae bacterium TAA 166

Project description:Acidobacteriaceae bacterium TAA 166

| PRJNA190839 | ENA

RNA-seq Analysis of Prmt1f/f and Lrat-Cre; Prmt1f/f Mouse Fibrotic Liver Transcriptomes

Project description:Purpose: To identify the alterations of genes transcriptional profile of livers obtained from Prmt1f/f mice and Lrat-Cre; Prmt1f/f mice treated with thioacetamide (TAA). Methods: Lrat-Cre mice were crossed with and Prmt1f/f mice to generate Lrat-Cre; Prmt1f/f mice. Prmt1f/f mice and Lrat-Cre; Prmt1f/f mice were treated with TAA (400mg/L, drinking water for 16 weeks) to induce liver fibrosis. Liver mRNA profiles of 10-week-old Prmt1f/f and Lrat-Cre; Prmt1f/f mice treated with TAA were generated by deep sequencing, using Illumina Novaseq 6000. We applied DESeq2 algorithm to filter the differentially expressed genes, after the significant analysis and FDR analysis under the following criteria: i) |log2FC| > 1 ; ii) Pvalue < 0.05. RT–PCR validation was performed using SYBR Green PCR Kit. Results: We identified 16916 transcripts in the livers of Prmt1f/f and Lrat-Cre; Prmt1f/f mice. 726 transcripts showed differential expression between Prmt1f/f and Lrat-Cre; Prmt1f/f livers, with a |log2FC| > 1 and P value < 0.05. Altered expression of 4 genes was confirmed by qRT–PCR. Conclusion: Our study represents the first detailed analysis of liver transcriptomes of Lrat-Cre; Prmt1f/f mice during liver fibrogenesis. RNA-seq based transcriptome analysis would provide us better understanding of complex biologic functions of Prmt1 in the hepatic stellate cell during the pricess of hepatic fibrogenesis in mice.

2022-02-07 | GSE196115 | GEO

Genome-wide chromatin accessibility profiles of zebrafish liver cells in thioacetamide (TAA) model

Project description:Zebrafish transgenic lines Tg(fabp10a:dsRed), Tg(hand2:EGFP) and Tg(kdrl:ras-mCherry) in AB wild-type background were anesthetized with MS-222 and adult females were injected intraperitoneally with 500 mg/kg thioacetamide (TAA) or sterile water as a control 6 times over the course of 2 weeks. We have characterized chromatin accessibility profiles of FACS-isolated hepatocytes (dsRed+), stellate cells (EGFP+) and liver endothelial cells (mCherry+) from fishes treated with TAA or sterile water. Cells negative for the fluorescence were used as a control.

2021-12-23 | GSE145563 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data